Odronextamab

• A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressi… Recruiting
  2022-502783-21-00 Phase III 10 countries Regeneron Pharmaceuticals Inc.
• A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting
  2022-502660-20-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Recruiting
  2024-510575-38-00 Phase II/III 6 countries The University Of Birmingham
• A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting
  2022-502113-28-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part… Recruiting
  2022-503092-28-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previo… Ended
  2024-511747-25-00 Phase II 5 countries Regeneron Pharmaceuticals Inc.

Showing 1–6 of 6 trials